136 related articles for article (PubMed ID: 12707542)
41. Collagen-based wound dressing for doxycycline delivery: in-vivo evaluation in an infected excisional wound model in rats.
Adhirajan N; Shanmugasundaram N; Shanmuganathan S; Babu M
J Pharm Pharmacol; 2009 Dec; 61(12):1617-23. PubMed ID: 19958583
[TBL] [Abstract][Full Text] [Related]
42. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
43. Carbohydrate-derived fulvic acid is a highly promising topical agent to enhance healing of wounds infected with drug-resistant pathogens.
Zhao Y; Paderu P; Delmas G; Dolgov E; Lee MH; Senter M; Park S; Leivers S; Perlin DS
J Trauma Acute Care Surg; 2015 Oct; 79(4 Suppl 2):S121-9. PubMed ID: 26406424
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
[TBL] [Abstract][Full Text] [Related]
45. The effect of topical negative pressure on wound biofilms using an in vitro wound model.
Ngo QD; Vickery K; Deva AK
Wound Repair Regen; 2012; 20(1):83-90. PubMed ID: 22126340
[TBL] [Abstract][Full Text] [Related]
46. Silver sulfadiazine (AgSD) resistant pseudomonas infection in experimental burn wounds.
Modak SM; Stanford JW; Bradshaw W; Fox CL
Panminerva Med; 1983; 25(3):181-8. PubMed ID: 6669393
[No Abstract] [Full Text] [Related]
47. A novel wound dressing with an antibiotic delivery system stimulated by microbial infection.
Suzuki Y; Tanihara M; Nishimura Y; Suzuki K; Kakimaru Y; Shimizu Y
ASAIO J; 1997; 43(5):M854-7. PubMed ID: 9360167
[TBL] [Abstract][Full Text] [Related]
48. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
[TBL] [Abstract][Full Text] [Related]
49. [Preliminary study on the improvement of wound microcirculation and retrospection on several methods of the management of deep partial thickness burn wound].
Sun YH; Yu DN; Chen X; Hu XH; Zhang GA; Yan RY; Tan FJ
Zhonghua Shao Shang Za Zhi; 2005 Feb; 21(1):17-20. PubMed ID: 15796836
[TBL] [Abstract][Full Text] [Related]
50. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone.
Costagliola M; Agrosì M
Curr Med Res Opin; 2005 Aug; 21(8):1235-40. PubMed ID: 16083533
[TBL] [Abstract][Full Text] [Related]
51. Topical silver treatment after escharectomy of infected full thickness burn wounds in rats.
Chu CS; McManus AT; Mason AD; Pruitt BA
J Trauma; 2005 May; 58(5):1040-6. PubMed ID: 15920422
[TBL] [Abstract][Full Text] [Related]
52. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
[TBL] [Abstract][Full Text] [Related]
53. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit.
Armour AD; Shankowsky HA; Swanson T; Lee J; Tredget EE
J Trauma; 2007 Jul; 63(1):164-71. PubMed ID: 17622885
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
55. Improvement in survival with peptidyl membrane interactive molecule D4B treatment after burn wound infection.
Gamelli RL; He LK; Liu H; Ricken JD
Arch Surg; 1998 Jul; 133(7):715-20. PubMed ID: 9687998
[TBL] [Abstract][Full Text] [Related]
56. [The establishment of a rat model of chronic pulmonary infection due to Pseudomonas aeruginosa].
Wang WF; Fang XQ; Liu YN
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):46-50. PubMed ID: 18346380
[TBL] [Abstract][Full Text] [Related]
57. Ethosomal Curcumin Promoted Wound Healing and Reduced Bacterial Flora in Second Degree Burn in Rat.
Partoazar A; Kianvash N; Darvishi MH; Nasoohi S; Rezayat SM; Bahador A
Drug Res (Stuttg); 2016 Dec; 66(12):660-665. PubMed ID: 27626605
[No Abstract] [Full Text] [Related]
58. SILVER versus other antimicrobial dressings: best practices!
Woo KY; Ayello EA; Sibbald RG
Surg Technol Int; 2008; 17():50-71. PubMed ID: 18802883
[TBL] [Abstract][Full Text] [Related]
59. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.
Steinstraesser L; Tack BF; Waring AJ; Hong T; Boo LM; Fan MH; Remick DI; Su GL; Lehrer RI; Wang SC
Antimicrob Agents Chemother; 2002 Jun; 46(6):1837-44. PubMed ID: 12019098
[TBL] [Abstract][Full Text] [Related]
60. Silver against Pseudomonas aeruginosa biofilms.
Bjarnsholt T; Kirketerp-Møller K; Kristiansen S; Phipps R; Nielsen AK; Jensen PØ; Høiby N; Givskov M
APMIS; 2007 Aug; 115(8):921-8. PubMed ID: 17696948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
